Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04054011Phase 1Completed
Phase 1, open-label, single-arm trial of Neobella in obesity, sponsored by University of California, San Diego. Primary endpoints: Number of Participants With Adverse Events, Thigh Circumference Change and 2 more. Started Jul 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04054011.